News
CHE
574.21
-7.08%
-43.74
Chemed Corp is Now Oversold (CHE)
NASDAQ · 3h ago
Chemed Corp Breaks Below 200-Day Moving Average - Notable for CHE
NASDAQ · 4h ago
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
NASDAQ · 7h ago
Chemed (CHE) Receives a Rating Update from a Top Analyst
TipRanks · 7h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
TipRanks · 8h ago
Chemed (CHE) Q1 Earnings Miss Estimates
NASDAQ · 21h ago
Chemed Corp reports results for the quarter ended in March - Earnings Summary
Chemed Corp reports quarterly adjusted earnings of $5.20 per share for the quarter ended in March. Revenue rose 5.2% to $589.23 million from a year ago. The company reported quarterly income of $65.02 million. Chemed Corp shares had fallen by 4.0% this quarter and gained 5.4% this year.
Reuters · 21h ago
Chemed Corp. Announces Increase In Q1 Income, but misses estimates
NASDAQ · 22h ago
Chemed Sees FY24 EPS $23.30-$23.70 Vs $23.52 Est.
Management reiterates its estimated full-year 2024 earnings per diluted share guidance range of $23.30 to $24.70. Management anticipates providing updated 2024 earnings guidance in June 30, 2024 earnings release. The company expects to report results for the year on June 30.
Benzinga · 22h ago
Chemed Non-GAAP EPS of $5.20 misses by $0.28, revenue of $589.2M misses by $1.9M
Chemed's Q1 non-GAAP EPS of $5.20 misses by $0.28, revenue of $589.2M misses by $1.9M. VITAS segment operating results: Net Patient Revenue of $354.0 million up 14.0%.
Seeking Alpha · 23h ago
CHEMED CORP - REITERATES ITS ESTIMATED FULL-YEAR 2024 EARNINGS PER DILUTED SHARE
Reuters · 23h ago
Chemed 2024 Earnings Preview
Chemed is scheduled to announce earnings on Wednesday, April 24th. The consensus EPS Estimate is $5.48 and the consensus revenue estimate is $591.1M. Over the last 2 years, CHE has beaten EPS estimates 88% of the time.
Seeking Alpha · 1d ago
Additions and deletions of Oppenheimer’s OPCO Trifecta
Oppenheimer analysts expect rates to moderate and be the catalyst for a rally by the second half of this year. The 10-year US Treasury yield increased to 4.6% and the S&P 500 is down about 4.5%. The VIX index rose 50% above its three-month low. Oppenheimer also updated their OPCO Trifecta list.
Seeking Alpha · 2d ago
Weekly Report: what happened at CHE last week (0415-0419)?
Weekly Report · 3d ago
DGRO's Underlying Holdings Imply 11% Gain Potential
NASDAQ · 6d ago
Press Release: VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase. VITAS is the nation's largest provider of end-of-life hospice care.
Dow Jones · 04/17 14:00
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation, announced the completion of the purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. For an aggregate purchase price of $85 million. The transaction closed effective April 17, 2024. Chemed is the nation's largest provider of end-of-life hospice care.
Barchart · 04/17 09:00
Weekly Report: what happened at CHE last week (0408-0412)?
Weekly Report · 04/15 09:28
Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)
TipRanks · 04/09 15:50
Chemed Insiders Sell US$20m Of Stock, Possibly Signalling Caution
Chemed Corporation insiders sold US$1.5m worth of shares in the last year. The biggest insider sale was by David Williams for US$3.5 million. Chemed insiders didn't buy any shares over the last 12 months. The company boasts high insider ownership. But Chemed's history of share sales could be a warning sign for investors. The insider sale of Chemed Corporation shares was made over the past year.
Simply Wall St · 04/08 10:41
More
Webull provides a variety of real-time CHE stock news. You can receive the latest news about Chemed Corp through multiple platforms. This information may help you make smarter investment decisions.
About CHE
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.